The Company is a Korea-based company mainly engaged in the production and sale of cosmetics. Along with subsidiaries, the Company operates its business through two segments. The Cosmetic segment is involved in the manufacturing and sale of cosmetics including basic cosmetics, mask packs, and patches. In addition, it is also engaged in the production and sale of body, hair care products and fragrances. The cosmetics are sold under the names of Botalinum, Mediheal N.M.F, Meditime, among others. The Pharmaceutical segment is engaged in the manufacturing and sale of over the counter (OTC) drugs, ethical the counter (ETC) drugs, as well as quasi drugs. The OTC drugs include anti-inflammatory analgesics and dementia treatments. The Company distributes its products within the domestic market and to overseas markets. The Company was established on May 29, 2000. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on July 12, 2018.
Headquarters
10, Bongeunsa-Ro 104-Gil, Gangnam-Gu
Seoul; Seoul;
Contact Details: Purchase the Icure Pharmaceutical Incorporation report to view the information.
Website: http://icure.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service